AMR is inevitable. As people keep finding ways to kill the microbes that infect us, those microbes, through evolutionary processes, will mutate to counteract them.

The UK’s report, A review of Antimicrobial Resistance,  is a well-considered blueprint of a financially viable way forward. While it may not find its way to your nightstand, it should be required reading for our legislatures.

A team of international researchers, in collaboration with the World Health Organization, recently assessed the share of global disease burden that was directly attributable to environmental risks. Their findings were published in the Journal of Public Health.

With medical letters and the general health of the presidential candidates recently being the big topic of discussion, who's medically fit or unfit in 2016?  What condition would cause you, or a major party, to disqualify someone running for President of the United States? (The answer is different for a physician.)

Karl Meltzer's newest feat, setting the land speed record traversing the Appalachian Trail from Maine to Georgia, was unquestionably remarkable -- and newsworthy. Yet among its media coverage, two of the most prominent reports played up the angle that one particular aspect of his achievement — the ultra runner's food consumption during his historic dash — was in some way bizarre. However, for the most part, that was just not the case.

In the science community, when dealing with people who are either evangelists in a war they know little about or are simply anti-science, this is known as "moving the goalposts." Basically, you just keep changing your argument every time the old one is shown to be invalid. That is what Greg Glassman, CEO of CrossFit, is doing.

Golden rice — bioengineered to contain beta-carotene — has the potential to decrease the toll of blindness and mortality due to vitamin A deficiency in the developing world. A new study modeled this potential when varying degrees of substitution and beta carotene content are involved. For the poorest, the benefit can be substantial.

For this issue, why should an economist lead? Why not a health economist? The answer: Many of the urgent problems are economic, so we need an economist, especially one versed in macro-economic issues and the world economy. To stop the global rise of drug-resistant infections, there's a supply-and-demand problem that needs to be fixed.

A water birth video recently went viral without much mention of safety. Proponents of this fringe delivery method are solving a problem that we don't have. Human birth is an unpredictable and often traumatic journey — so why add a risk factor to an already-risky endeavor?

In an excerpt from Morning Consult, Dr. Robert Popovian, Senior Director of Pfizer US Government Relations, offers five suggestions for policy makers about pricing, cost, and value of innovative therapies.

First came the mosquitoes.
Now, the houseflies.  They buzz around the TV screen, land on your head, and they won't leave you alone! What do these trespassers actually want anyway? And why do they like us humans so much?